[go: up one dir, main page]

BG105009A - Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline - Google Patents

Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline

Info

Publication number
BG105009A
BG105009A BG105009A BG10500900A BG105009A BG 105009 A BG105009 A BG 105009A BG 105009 A BG105009 A BG 105009A BG 10500900 A BG10500900 A BG 10500900A BG 105009 A BG105009 A BG 105009A
Authority
BG
Bulgaria
Prior art keywords
carboxyamino
tetrahydroquinoline
substituted
producing
preparation
Prior art date
Application number
BG105009A
Other languages
Bulgarian (bg)
English (en)
Inventor
David DAMON
Robert DUGGER
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of BG105009A publication Critical patent/BG105009A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG105009A 1999-11-30 2000-11-30 Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline BG105009A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16796799P 1999-11-30 1999-11-30

Publications (1)

Publication Number Publication Date
BG105009A true BG105009A (en) 2001-11-30

Family

ID=22609556

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105009A BG105009A (en) 1999-11-30 2000-11-30 Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline

Country Status (45)

Country Link
US (1) US6313142B1 (uk)
EP (1) EP1125929B1 (uk)
JP (1) JP3579345B2 (uk)
KR (1) KR100408177B1 (uk)
CN (1) CN1173953C (uk)
AP (1) AP2000002011A0 (uk)
AR (1) AR029775A1 (uk)
AT (1) ATE315028T1 (uk)
AU (1) AU784694B2 (uk)
BG (1) BG105009A (uk)
BR (1) BR0005636A (uk)
CA (1) CA2327029C (uk)
CO (1) CO5261552A1 (uk)
CY (1) CY1104989T1 (uk)
CZ (1) CZ20004407A3 (uk)
DE (1) DE60025317T2 (uk)
DK (1) DK1125929T3 (uk)
DZ (1) DZ3079A1 (uk)
EA (1) EA003668B1 (uk)
EE (1) EE200000659A (uk)
ES (1) ES2254109T3 (uk)
GE (1) GEP20022798B (uk)
GT (1) GT200000190A (uk)
HK (1) HK1038007A1 (uk)
HN (1) HN2000000203A (uk)
HR (1) HRP20000804A2 (uk)
HU (1) HUP0004747A3 (uk)
ID (1) ID28489A (uk)
IL (1) IL139849A (uk)
IS (1) IS5715A (uk)
MA (1) MA25223A1 (uk)
NO (1) NO20006039L (uk)
NZ (1) NZ508509A (uk)
OA (1) OA11494A (uk)
PA (1) PA8503801A1 (uk)
PE (1) PE20010913A1 (uk)
PL (1) PL344208A1 (uk)
SG (1) SG102603A1 (uk)
SK (1) SK17792000A3 (uk)
TN (1) TNSN00230A1 (uk)
TW (1) TW591016B (uk)
UA (1) UA65615C2 (uk)
UY (1) UY26451A1 (uk)
YU (1) YU71500A (uk)
ZA (1) ZA200006947B (uk)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2000000203A (es) * 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.
AU2002361811A1 (en) 2001-12-19 2003-07-09 Atherogenics, Inc. 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
MXPA04005864A (es) * 2001-12-19 2004-10-29 Atherogenics Inc Derivados de charcona y su uso para tratar enfermedades.
US7279297B2 (en) * 2002-04-11 2007-10-09 Roar Holding Llc Ex vivo method for determination of CETP activity and efficacy of heart disease treatment
US20090181966A1 (en) * 2002-10-04 2009-07-16 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
US7504508B2 (en) * 2002-10-04 2009-03-17 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
JP2006508077A (ja) * 2002-10-04 2006-03-09 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 炎症疾患を治療するためのｐｇｄ２レセプタアンタゴニスト
US7223870B2 (en) * 2002-11-01 2007-05-29 Pfizer Inc. Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
US20040181075A1 (en) * 2002-12-19 2004-09-16 Weingarten M. David Process of making chalcone derivatives
WO2004056358A1 (en) 2002-12-20 2004-07-08 Pfizer Products Inc. Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor
US20040132771A1 (en) * 2002-12-20 2004-07-08 Pfizer Inc Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
EP1601655A2 (en) * 2003-03-04 2005-12-07 Takasago International Corporation Method for producing optically active amines
AU2004222436A1 (en) * 2003-03-17 2004-09-30 Japan Tobacco Inc. Method for increasing the oral bioavailability of S-(2-(((1- (2-ethylbutyl) cyclohexyl)carbonyl) amino) phenyl)-2-methylpropanethioate
WO2004082593A2 (en) * 2003-03-17 2004-09-30 Japan Tobacco Inc. Pharmaceutical compositions of cetp inhibitors
TWI494102B (zh) * 2003-05-02 2015-08-01 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
EA200600737A1 (ru) * 2003-10-08 2006-10-27 Эли Лилли Энд Компани Соединения и способы для лечения дислипидемии
UA90269C2 (uk) * 2004-04-02 2010-04-26 Мицубиси Танабе Фарма Корпорейшн Тетрагідрохінолінові похідні і спосіб їх одержання
MXPA06014716A (es) * 2004-06-24 2007-03-12 Lilly Co Eli Compuestos y metodos para el tratamiento de dislipidemia.
DOP2005000123A (es) * 2004-07-02 2011-07-15 Merck Sharp & Dohme Inhibidores de cetp
WO2006033001A1 (en) * 2004-09-23 2006-03-30 Pfizer Products Inc. Quinoline compounds
WO2006069162A1 (en) * 2004-12-20 2006-06-29 Reddy Us Therapeutics, Inc. Novel heterocyclic compounds and their pharmaceutical compositions
UA90706C2 (uk) * 2005-02-24 2010-05-25 Милленниум Фармасьютикалз, Инк. Антагоністи рецептора pgd2 для лікування запальних захворювань
TW200808731A (en) 2006-03-30 2008-02-16 Tanabe Seiyaku Co A process for preparing tetrahydroquinoline derivatives
CL2008000684A1 (es) 2007-03-09 2008-08-01 Indigene Pharmaceuticals Inc Composicion farmaceutica que comprende metformina r-(+) lipoato y un inhibidor de reductasa hmg-coa; formulacion de dosis unitaria; y uso en el tratamiento de una complicacion diabetica.
CN101429160B (zh) * 2007-11-06 2011-10-19 上海药明康德新药开发有限公司 一种1-r-4-氨基-1,2,3,4-四氢喹啉的合成方法
AR077208A1 (es) * 2009-06-30 2011-08-10 Lilly Co Eli Derivados del acido trans-4-[[(5s)-5-[[[3,5-bis(trifluorometil) fenil] metil] (2-metil-2h-tetrazol-5-il) amino) -2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il) metil)-ciclohexancarboxilico y sus formas cristalinas, composiciones farmaceuticas que los comprenden, su uso para preparar un medicam
IL317973A (en) 2022-07-05 2025-02-01 Newamsterdam Pharma B V Salts of ovicetrapib and processes for their production and intermediates

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7870M (uk) * 1968-11-08 1970-04-27
US3971789A (en) 1972-10-21 1976-07-27 John Wyeth & Brother Limited O-(4-Quinolylamino)benzamides
GB8432091D0 (en) 1984-12-19 1985-01-30 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
US4839368A (en) 1986-05-02 1989-06-13 Mochida Pharmaceutical Co., Ltd. 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives
GB8804444D0 (en) 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5231102A (en) 1989-03-08 1993-07-27 Merck Sharp & Dohme, Ltd. Tetrahydroquinoline derivatives useful for neurodegenerative disorders
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US6140342A (en) 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
US6197786B1 (en) 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
US6147089A (en) 1998-09-17 2000-11-14 Pfizer Inc. Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
HN2000000203A (es) * 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.

Also Published As

Publication number Publication date
JP3579345B2 (ja) 2004-10-20
OA11494A (en) 2004-05-07
ES2254109T3 (es) 2006-06-16
EE200000659A (et) 2001-08-15
EP1125929B1 (en) 2006-01-04
NZ508509A (en) 2001-06-29
SK17792000A3 (sk) 2002-10-08
DK1125929T3 (da) 2006-04-03
BR0005636A (pt) 2001-07-17
IS5715A (is) 2001-05-31
PE20010913A1 (es) 2001-09-10
EA200001129A2 (ru) 2001-06-25
KR100408177B1 (ko) 2003-12-01
CZ20004407A3 (cs) 2002-06-12
HRP20000804A2 (en) 2001-06-30
HN2000000203A (es) 2001-06-13
NO20006039D0 (no) 2000-11-29
MA25223A1 (fr) 2001-07-02
AU784694B2 (en) 2006-06-01
US6313142B1 (en) 2001-11-06
NO20006039L (no) 2001-05-31
TNSN00230A1 (fr) 2005-11-10
HUP0004747A2 (hu) 2001-10-28
CY1104989T1 (el) 2010-03-03
CN1173953C (zh) 2004-11-03
PA8503801A1 (es) 2002-07-30
DZ3079A1 (fr) 2004-10-24
JP2001163859A (ja) 2001-06-19
DE60025317D1 (de) 2006-03-30
KR20010052012A (ko) 2001-06-25
CA2327029A1 (en) 2001-05-30
CO5261552A1 (es) 2003-03-31
CN1302800A (zh) 2001-07-11
AR029775A1 (es) 2003-07-16
IL139849A (en) 2006-10-31
TW591016B (en) 2004-06-11
AU7178900A (en) 2001-05-31
DE60025317T2 (de) 2006-08-03
EA200001129A3 (ru) 2001-10-22
SG102603A1 (en) 2004-03-26
EA003668B1 (ru) 2003-08-28
YU71500A (sh) 2003-02-28
UY26451A1 (es) 2001-06-29
PL344208A1 (en) 2001-06-04
ATE315028T1 (de) 2006-02-15
CA2327029C (en) 2005-08-09
HUP0004747A3 (en) 2002-12-28
ZA200006947B (en) 2002-05-27
AP2000002011A0 (en) 2000-12-31
GEP20022798B (en) 2002-09-25
UA65615C2 (uk) 2004-04-15
HU0004747D0 (uk) 2001-02-28
HK1038007A1 (en) 2002-03-01
EP1125929A1 (en) 2001-08-22
GT200000190A (es) 2002-04-27
ID28489A (id) 2001-05-31
IL139849A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
BG105009A (en) Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline
PL345215A1 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
AU5439899A (en) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors
IL173393A0 (en) 4-carboxyamino-2- substituted-1,2,3,4- tetrahydroquinolines as cetp inhibitors
MXPA03009935A (es) Metodos e intermedios para preparar inhibidores 4-aminoquinolina de cetp.
AU4913800A (en) Method for condensing polyamides
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
HK1052940A1 (en) Synthetic methods for aplidine and new antitumoralderivatives, methods of making and using them
WO2003037863A3 (de) Substituierte indole, verfahren zu deren herstellung und deren verwendung zur schmerzbekämpfung
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
MY120237A (en) Method for the synthesis of quinoline derivatives
IL146811A0 (en) Novel method for preparing benzoperhydroisoindole compounds
BG103649A (en) Method for the preparation of eprosartan
BG106002A (en) Process for preparing pesticidal intermediates
BG103650A (en) Method for the preparation of eprosartan
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MX225445B (es) Metodo y produccion de n-fosfonometilglicina.
MXPA02003042A (es) Proceso para prevenir formacion de incrustaciones.
IL152295A0 (en) Method for producing 2-alkyl-3-chlorophenols
IL133923A0 (en) Method for preparing 3-cyano-2,4-dihalogen-5-fluoro-benzoic acid
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
YU62800A (sh) Postupak za proizvodnju r-(+)-6- karboksamido-3n-metilamino- 1,2,3,4-tetrahidrokarbazola
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine
AU6584601A (en) Method for producing indols
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.